Breast Cancer News

CancerConnect breast cancer news, tips, and features provide breaking research stories, helpful tips, and inspiring features related to ovarian cancer. The unique daily cancer news service evaluates all aspects of breast cancer research and reports on the developments that are most important to cancer patients and healthcare providers, while the tips and features offer insight into all aspects of breast cancer treatment and survivorship.

Share

Breast Cancer News


Study Confirms Role of Ovarian Suppression and Aromasin for Younger Women With Hormone-sensitive Breast Cancer (December 19, 2014)

CancerConnect News: Ovarian suppression combined with the anti-estrogen drug Aromasin® (exemestane) appears to greatly reduce the risk of breast cancer recurrence in younger women according to the results... Continue Reading

Breast Cancer Patients Are Now Living Longer without Relapse (December 18, 2014)

CancerConnect News: Survival without relapse for patients with early-stage breast cancer has improved significantly over the past 30 years, particularly among women with HER2-positive disease. These findings... Continue Reading

Some Older Women with Early-Stage Breast Cancer May Be Receiving Radiation That Is Unlikely to Add Benefit (December 17, 2014)

CancerConnect News Up to two-thirds of older women with early-stage breast cancer may be receiving radiation therapy that may not provide additional benefit. These findings were recently released online... Continue Reading

IBIS-I Trial Confirms Greater Than Fifteen Year Benefit of Tamoxifen to Reduce Risk of Breast Cancer in High-Risk Women (December 16, 2014)

CancerConnect News: Long term results of the International Breast Cancer Intervention Study-I (IBIS-I) were presented at the 2014 San Antonio Breast Cancer Symposium, confirming that tamoxifen significantly... Continue Reading

Neratinib Continues to Show Activity in HER2-Positive Breast Cancer (December 15, 2014)

CancerConnect News: Interim results from an ongoing Phase II clinical trial of neratinib were presented at the 2014 San Antonio Breast Cancer Symposium (SABCS). Neratinib is an investigational, oral medication... Continue Reading

Breastfeeding Reduces Risk of Developing Breast Cancer (December 12, 2014)

CancerConnect News:  Breastfeeding could cut the chance of developing breast cancer by up to one fifth according to researchers sharing the results of a major clinical study presented at the 2014 San... Continue Reading

Exercise Significantly Reduces Joint Pain Caused by Hormone Therapy Taken by Patients With Breast Cancer (December 12, 2014)

CancerConnect News: According to a study published this week in the Journal of Clinical Oncology regular exercise helps relieve arthritic joint pain associated with aromatase inhibitor (AI) drugs used... Continue Reading

German Study Demonstrate Significant Pathological Complete Response for Abraxane® in Early Stage Breast Cancer (December 11, 2014)

CancerConnect News: Doctors from Germany reported the results of a clinical trial at the San Antonio Breast Cancer Symposium (SABCS) demonstrating that Abraxane®(nab-paclitaxel) is superior to conventional... Continue Reading

Initial Results of PD-1 Checkpoint Inhibitors Evaluated in Triple-Negative Breast Cancer Presented in San Antonio (December 11, 2014)

CancerConnect News: The initial results from a phase 1 trial evaluating the checkpoint inhibitor Keytruda® (pembrolizumab) in patients with heavily pretreated triple-negative breast cancer were recently... Continue Reading

3-D Mammography Improves Cancer Detection in Dense Breasts (December 4, 2014)

A major new study being presented at the annual meeting of the Radiological Society of North America (RSNA) has found that digital breast tomosynthesis, also known as 3-D mammography, has the potential... Continue Reading

More Breast Cancer News

Latest Breast Cancer News By Stage


Screening and Prevention

IBIS-I Trial Confirms Greater Than Fifteen Year Benefit of Tamoxifen to Reduce Risk of Breast Cancer in High-Risk Women (December 16, 2014)

CancerConnect News: Long term results of the International Breast Cancer Intervention Study-I (IBIS-I) were presented at the 2014 San Antonio Breast Cancer Symposium, confirming that tamoxifen significantly decreased the risk of developing breast cancer... Continue Reading

Breastfeeding Reduces Risk of Developing Breast Cancer (December 12, 2014)

CancerConnect News:  Breastfeeding could cut the chance of developing breast cancer by up to one fifth according to researchers sharing the results of a major clinical study presented at the 2014 San Antonio Breast Cancer Symposium.1 Previous studies... Continue Reading

3-D Mammography Improves Cancer Detection in Dense Breasts (December 4, 2014)

A major new study being presented at the annual meeting of the Radiological Society of North America (RSNA) has found that digital breast tomosynthesis, also known as 3-D mammography, has the potential to significantly increase the cancer detection rate... Continue Reading

Risk-based Screening Misses Breast Cancers in Women in Their Forties (December 3, 2014)

A study of breast cancers detected with screening mammography found that strong family history and dense breast tissue were commonly absent in women between the ages of 40 and 49 diagnosed with breast cancer. Results of the study were presented at the... Continue Reading

October Is National Breast Cancer Awareness Month (October 10, 2014)

What does breast cancer awareness month mean to you? We’d like to hear from you—join us on facebook, twitter, or CancerConnect and join the discussion. On October 23rd at 6pm EDT, we will have a live web chat with UC San Diego Moores Cancer Center... Continue Reading

More Screening and Prevention

Carcinoma in Situ

Ask the Early-Stage Breast Cancer Expert: Now Available (October 23, 2014)

Rethink Pink: From Awareness to Knowledge, Advice for women newly diagnosed with early stage breast cancer Live Web Chat with Dr. Yashar: Recorded 10/23 Awareness of breast cancer risk and appreciation of the need for screening is important, but at this... Continue Reading

October Is National Breast Cancer Awareness Month (October 10, 2014)

What does breast cancer awareness month mean to you? We’d like to hear from you—join us on facebook, twitter, or CancerConnect and join the discussion. On October 23rd at 6pm EDT, we will have a live web chat with UC San Diego Moores Cancer Center... Continue Reading

Walk or Run Your Way to a Reduced Risk of Breast Cancer (September 24, 2014)

Want to reduce your risk of breast cancer? Lace up those shoes and get moving—because exercise has a significant impact. There is a growing body of evidence to indicate that exercise is crucial to reducing the risk of cancer. Now a new study has put... Continue Reading

Breast Conservation Therapy May Be Better than a Mastectomy (September 17, 2014)

Breast cancer claims the lives of approximately 40,000 women annually in the United States alone. Early-stage breast cancer refers to cancer that has not spread from its site of origin. Patients with early-stage breast cancer have a high cure rate with... Continue Reading

Risk of Breast Cancer Recurrence Doesn’t Increase with TNF Inhibitor Use (August 28, 2014)

According to the results of a recently published study from Swedish investigators treatment with tumor necrosis factor inhibitors (TNF) does not appear to increase the rate of breast cancer recurrence among patients with rheumatoid arthritis (RA).  The... Continue Reading

More Carcinoma in Situ

Stage I - Node Negative

Study Confirms Role of Ovarian Suppression and Aromasin for Younger Women With Hormone-sensitive Breast Cancer (December 19, 2014)

CancerConnect News: Ovarian suppression combined with the anti-estrogen drug Aromasin® (exemestane) appears to greatly reduce the risk of breast cancer recurrence in younger women according to the results of the Suppression of Ovarian Function Trial... Continue Reading

Breast Cancer Patients Are Now Living Longer without Relapse (December 18, 2014)

CancerConnect News: Survival without relapse for patients with early-stage breast cancer has improved significantly over the past 30 years, particularly among women with HER2-positive disease. These findings were recently published in the Journal of Clinical... Continue Reading

Some Older Women with Early-Stage Breast Cancer May Be Receiving Radiation That Is Unlikely to Add Benefit (December 17, 2014)

CancerConnect News Up to two-thirds of older women with early-stage breast cancer may be receiving radiation therapy that may not provide additional benefit. These findings were recently released online by the journal Cancer.[1] The goal of radiation... Continue Reading

Exercise Significantly Reduces Joint Pain Caused by Hormone Therapy Taken by Patients With Breast Cancer (December 12, 2014)

CancerConnect News: According to a study published this week in the Journal of Clinical Oncology regular exercise helps relieve arthritic joint pain associated with aromatase inhibitor (AI) drugs used to treat breast cancer.1 Aromatase inhibitors are... Continue Reading

Study Demonstrates Significant Increase in Early-Stage Breast Cancer Patients Electing Double Mastectomy (December 1, 2014)

The number of women with early-stage cancer involving one breast who elect to have both breasts removed has increased significantly, according to a new study of 1.2 million patients published in JAMA Surgery. Researchers at Vanderbilt University analyzed... Continue Reading

More Stage I Node Negative

Stages II-III

Study Confirms Role of Ovarian Suppression and Aromasin for Younger Women With Hormone-sensitive Breast Cancer (December 19, 2014)

CancerConnect News: Ovarian suppression combined with the anti-estrogen drug Aromasin® (exemestane) appears to greatly reduce the risk of breast cancer recurrence in younger women according to the results of the Suppression of Ovarian Function Trial... Continue Reading

Breast Cancer Patients Are Now Living Longer without Relapse (December 18, 2014)

CancerConnect News: Survival without relapse for patients with early-stage breast cancer has improved significantly over the past 30 years, particularly among women with HER2-positive disease. These findings were recently published in the Journal of Clinical... Continue Reading

Exercise Significantly Reduces Joint Pain Caused by Hormone Therapy Taken by Patients With Breast Cancer (December 12, 2014)

CancerConnect News: According to a study published this week in the Journal of Clinical Oncology regular exercise helps relieve arthritic joint pain associated with aromatase inhibitor (AI) drugs used to treat breast cancer.1 Aromatase inhibitors are... Continue Reading

German Study Demonstrate Significant Pathological Complete Response for Abraxane® in Early Stage Breast Cancer (December 11, 2014)

CancerConnect News: Doctors from Germany reported the results of a clinical trial at the San Antonio Breast Cancer Symposium (SABCS) demonstrating that Abraxane®(nab-paclitaxel) is superior to conventional solvent-based paclitaxel for the treatment of... Continue Reading

Study Demonstrates Significant Increase in Early-Stage Breast Cancer Patients Electing Double Mastectomy (December 1, 2014)

The number of women with early-stage cancer involving one breast who elect to have both breasts removed has increased significantly, according to a new study of 1.2 million patients published in JAMA Surgery. Researchers at Vanderbilt University analyzed... Continue Reading

More Stages II and III

Inflammatory

October Is National Breast Cancer Awareness Month (October 10, 2014)

What does breast cancer awareness month mean to you? We’d like to hear from you—join us on facebook, twitter, or CancerConnect and join the discussion. On October 23rd at 6pm EDT, we will have a live web chat with UC San Diego Moores Cancer Center... Continue Reading

Walk or Run Your Way to a Reduced Risk of Breast Cancer (September 24, 2014)

Want to reduce your risk of breast cancer? Lace up those shoes and get moving—because exercise has a significant impact. There is a growing body of evidence to indicate that exercise is crucial to reducing the risk of cancer. Now a new study has put... Continue Reading

Risk of Breast Cancer Recurrence Doesn’t Increase with TNF Inhibitor Use (August 28, 2014)

According to the results of a recently published study from Swedish investigators treatment with tumor necrosis factor inhibitors (TNF) does not appear to increase the rate of breast cancer recurrence among patients with rheumatoid arthritis (RA).  The... Continue Reading

Making Informed Decisions about Breast Reconstruction, featuring an expert from Memorial Sloan Kettering Cancer Center (July 16, 2014)

Memorial Sloan Kettering Cancer Center expert Andrea L. Pusic, MD, MHS, FRCSC, discussed and answered participants’ questions about reconstruction after breast cancer surgery during a live Web chat on July 16, 2014. The recorded version of the Web... Continue Reading

Multiple Studies Presented at ASCO® Annual Meeting Demonstrate Unique, Practice-Changing Impact of Oncotype DX® to Optimize Cancer Care (June 9, 2014)

New Study Shows Oncotype DX® DCIS Score™ Changes Treatment Recommendations for One Out of Three DCIS Patients Fifth Direct Comparison Study Confirms Oncotype DX, the Only Test Shown to Predict Chemotherapy Benefit, is Different from Other Multi-Gene... Continue Reading

More Inflammatory

Metastatic

Neratinib Continues to Show Activity in HER2-Positive Breast Cancer (December 15, 2014)

CancerConnect News: Interim results from an ongoing Phase II clinical trial of neratinib were presented at the 2014 San Antonio Breast Cancer Symposium (SABCS). Neratinib is an investigational, oral medication that targets HER2 as well as HER4 and the... Continue Reading

Second-line Avastin Improves Progression-Free Survival in Advanced HER2-Negative Breast Cancer (October 20, 2014)

Adding Avastin® (bevacizumab) to chemotherapy in second-line treatment of advanced HER2-negative breast cancer improves progression-free survival. Results of the phase III TANIA trial evaluating the role of Avastin® in advanced breast cancer were recently... Continue Reading

October Is National Breast Cancer Awareness Month (October 10, 2014)

What does breast cancer awareness month mean to you? We’d like to hear from you—join us on facebook, twitter, or CancerConnect and join the discussion. On October 23rd at 6pm EDT, we will have a live web chat with UC San Diego Moores Cancer Center... Continue Reading

Impressive Survival Gains with New First-Line Therapy for HER2-Positive Metastatic Breast Cancer (October 9, 2014)

According to recent findings, the combination of targeted agents Herceptin (trastuzumab) and Perjeta (perjeta) significantly improves survival for patients with HER2-positive metastatic breast cancer when added to chemotherapy. This data was presented... Continue Reading

Walk or Run Your Way to a Reduced Risk of Breast Cancer (September 24, 2014)

Want to reduce your risk of breast cancer? Lace up those shoes and get moving—because exercise has a significant impact. There is a growing body of evidence to indicate that exercise is crucial to reducing the risk of cancer. Now a new study has put... Continue Reading

More Metastatic

Recurrent

Breast Cancer Patients Are Now Living Longer without Relapse (December 18, 2014)

CancerConnect News: Survival without relapse for patients with early-stage breast cancer has improved significantly over the past 30 years, particularly among women with HER2-positive disease. These findings were recently published in the Journal of Clinical... Continue Reading

Neratinib Continues to Show Activity in HER2-Positive Breast Cancer (December 15, 2014)

CancerConnect News: Interim results from an ongoing Phase II clinical trial of neratinib were presented at the 2014 San Antonio Breast Cancer Symposium (SABCS). Neratinib is an investigational, oral medication that targets HER2 as well as HER4 and the... Continue Reading

Second-line Avastin Improves Progression-Free Survival in Advanced HER2-Negative Breast Cancer (October 20, 2014)

Adding Avastin® (bevacizumab) to chemotherapy in second-line treatment of advanced HER2-negative breast cancer improves progression-free survival. Results of the phase III TANIA trial evaluating the role of Avastin® in advanced breast cancer were recently... Continue Reading

October Is National Breast Cancer Awareness Month (October 10, 2014)

What does breast cancer awareness month mean to you? We’d like to hear from you—join us on facebook, twitter, or CancerConnect and join the discussion. On October 23rd at 6pm EDT, we will have a live web chat with UC San Diego Moores Cancer Center... Continue Reading

Impressive Survival Gains with New First-Line Therapy for HER2-Positive Metastatic Breast Cancer (October 9, 2014)

According to recent findings, the combination of targeted agents Herceptin (trastuzumab) and Perjeta (perjeta) significantly improves survival for patients with HER2-positive metastatic breast cancer when added to chemotherapy. This data was presented... Continue Reading

More Recurrent

Supportive Care

October Is National Breast Cancer Awareness Month (October 10, 2014)

What does breast cancer awareness month mean to you? We’d like to hear from you—join us on facebook, twitter, or CancerConnect and join the discussion. On October 23rd at 6pm EDT, we will have a live web chat with UC San Diego Moores Cancer Center... Continue Reading

Risk of Breast Cancer Recurrence Doesn’t Increase with TNF Inhibitor Use (August 28, 2014)

According to the results of a recently published study from Swedish investigators treatment with tumor necrosis factor inhibitors (TNF) does not appear to increase the rate of breast cancer recurrence among patients with rheumatoid arthritis (RA).  The... Continue Reading

Making Informed Decisions about Breast Reconstruction, featuring an expert from Memorial Sloan Kettering Cancer Center (July 16, 2014)

Memorial Sloan Kettering Cancer Center expert Andrea L. Pusic, MD, MHS, FRCSC, discussed and answered participants’ questions about reconstruction after breast cancer surgery during a live Web chat on July 16, 2014. The recorded version of the Web... Continue Reading

Ask the Expert: Breast Cancer, Diet and Exercise (May 19, 2014)

CancerConnect recently partnered with Dana-Farber to provide you with the opportunity to engage with a breast cancer expert, Jennifer A. Ligibel, MD, of the Susan F. Smith Center for Women’s Cancers at Dana-Farber. On May 7 and 8, 2014, Dr. Ligibel... Continue Reading

Dana-Farber Expert Answers Questions about Breast Cancer, Diet and Exercise (April 25, 2014)

CancerConnect and Dana-Farber Cancer Institute Present: Ask the Expert with Dr. Ligibel CancerConnect recently partnered with Dana-Farber to provide you with the opportunity to engage with a breast cancer expert, Jennifer A. Ligibel, MD, of the Susan... Continue Reading

More Supportive Care

CancerConnect Cancer Commuity & Discussions


Cancer Types

Sign up for the CancerConnect newsletter

Sign up for our newsletter and receive the latest news and updates about specific types of cancer.

  Close |  Please don't show me this again

Just another WordPress weblog
Facebook Twitter RSS